Patent details

Basic Information

Publication number:

EP2897588

PCT Application Number:

US2014066872

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148092489

PCT Publication Number:

WO2015077594

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

AN INHALABLE MEDICAMENT

French Title of Invention:

MÉDICAMENT INHALABLE

German Title of Invention:

INHALIERBARES MEDIKAMENT

SPC Number:

Dates

Filing date:

21/11/2014

Grant date:

17/07/2019

EP Publication Date:

29/07/2015

PCT Publication Date:

28/05/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/07/2019

EP B1 Publication Date:

17/07/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/11/2019

Expiration date:

21/11/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/07/2019

 

 

Name:

Teva Branded Pharmaceutical Products R&D, Inc.

Address:

41 Moores Road, Frazer PA 19355, United States (US)

Inventor

1

Name:

WU, Libo

Address:

United States (US)

2

Name:

DALVI, Mukui

Address:

United States (US)

Priority

Priority Number:

201361907782 P

Priority Date:

22/11/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00;

Publication

European Patent Bulletin

1

Issue number:

201929

Publication date:

17/07/2019

Description:

Grant (B1)

2

Issue number:

202012

Publication date:

18/03/2020

Description:

Opposition procedure started

3

Issue number:

202215

Publication date:

13/04/2022

Description:

Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages